September 22, 2026 | ASCO, Congress, Pharma, healthcare, oncology
As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

The pace of innovation in oncology is accelerating, bringing more data, more complex science, and more information for HCPs to navigate.
Our latest oncology congress eBook explores what this means for life sciences organizations and how congress experiences can help turn scientific innovation into understanding.
Discover insights on:
Making meaningful connections in an age of accelerated innovation
Creating more effective congress experiences
The future of congress engagement for life sciences companies
Emerging trends shaping oncology commercialization
Why a connected approach is key to congress success
This content was provided by Inizio
Latest Content from Inizio
Published in pharmaphorum October 2015 by Laurent Chanroux
Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.
Published in eyeforpharma 12 October by Rachel Howard
Overview of spondyloarthritis patient profiles and treatment pathways.
How study design which reflects doctors’ real world choices can optimise results.
Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.
Published in eyeforpharma July 29 by Rachel Howard
HCPs predict the future of the biologics market
What do you know about chaos theory?
Published in pharmaphorum July 2015 by Julie Denny
